SOX2 Human shRNA Plasmid Kit (Locus ID 6657)
SOX2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
|Product Name||SOX2 Human shRNA Plasmid Kit (Locus ID 6657)|
|Kit Components||SOX2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 6657). 5µg purified plasmid DNA per constructNon-effective 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.|
|Summary||This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (SOX2OT). [provided by RefSeq, Jul 2008].|
|shRNA Design||These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, align it with our published shRNA design sequences. If these do not align, please utilize our custom shRNA service|
|Performance Guaranteed||OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at firstname.lastname@example.org. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).
|The use of this RNAi has been cited in the following citations:|
SOX2 expression in the developing, adult, as well as, diseased prostate
,Yu, X;Cates, JM;Morrissey, C;You, C;Grabowska, MM;Zhang, J;DeGraff, DJ;Strand, DW;Franco, OE;Lin-Tsai, O;Hayward, SW;Matusik, RJ;,
Prostate Cancer Prostatic Dis. Aug 2014,PubMed ID 25091041